TGFB1 and chronic kidney disease: Above all, these findings uncover the causal role of SIRT2 in the progression of renal fibrosis through the control of TGF-β/SMAD signaling and suggest that SIRT2 has the potential to be an effective therapeutic approach for both prevention and treatment of renal fibrosis as part of CKD.